The ARExVisual® System is a high-performance chromogenic detection platform designed to maximize the utility of primary antibodies in life science research and clinical diagnostics. Engineered for exceptional sensitivity, clarity, and reproducibility, it enables robust visualization of target biomarkers across a wide range of applications, from routine pathology to advanced translational research.

This system delivers sharp, high-contrast signals that make primary antibody-based detection of disease-related biomarkers straightforward and reliable. It supports critical applications including:

・Detection and localization of diagnostic biomarkers for cancer, diabetes, Parkinson’s disease, and Alzheimer’s disease, supporting both basic research and clinical pathology workflows.

・Investigation of therapeutic agents’ absorption, distribution, metabolism, and excretion (ADME) profiles in preclinical studies.

・Assessment of multi-drug resistance (MDR) mechanisms, enabling researchers to evaluate drug efficacy and resistance pathways with confidence.

Compatible with both formalin-fixed paraffin-embedded (FFPE) and frozen tissue sections, the ARExVisual® System produces stable, lightfast chromogenic signals ideal for brightfield microscopy and digital slide scanning. Its optimized reaction chemistry minimizes background noise and maximizes signal-to-noise ratio, ensuring clear, quantifiable results that support accurate interpretation, documentation, and long-term archiving of samples.